Psilocybin mushrooms make you trip because they contain a chemical that mimics serotonin, one of your brain’s key signaling molecules. Once you eat the mushroom, your body converts psilocybin into an active compound called psilocin, which binds to serotonin receptors and dramatically alters how your brain processes information, perceives the world, and constructs your sense of self.
From Mushroom to Brain: The Conversion Step
Psilocybin itself doesn’t actually do much. It’s a prodrug, meaning your body has to transform it before it becomes active. When you eat a psilocybin mushroom, enzymes in your intestines and kidneys strip away a phosphate group from the psilocybin molecule. What’s left is psilocin, a smaller, fat-soluble molecule that can slip across the blood-brain barrier, the protective layer that keeps most chemicals out of your brain.
This conversion happens quickly. Psilocin levels in the blood peak around two hours after eating the mushroom, and the subjective effects of a trip last roughly six hours total. The speed of this conversion is why most people start feeling something within 20 to 40 minutes of eating mushrooms, though it can take longer depending on stomach contents.
How Psilocin Hijacks the Serotonin System
Psilocin’s molecular structure looks remarkably similar to serotonin, a neurotransmitter involved in mood, perception, and cognition. Because of this resemblance, psilocin binds with high affinity to a specific type of serotonin receptor called 5-HT2A. These receptors are concentrated in the cortex, the outer layer of your brain responsible for higher-order thinking, sensory processing, and self-awareness.
When psilocin locks onto these receptors, it activates them in ways that normal serotonin signaling doesn’t. The receptor triggers internal signaling cascades that change how neurons fire and communicate. Psilocin also binds to other serotonin receptor subtypes, but the 5-HT2A receptor is the primary driver of the psychedelic experience. Blocking this receptor with a specific antagonist eliminates the trip entirely, confirming it as the key mechanism.
Why You See Things That Aren’t There
The visual hallucinations that define a mushroom trip have a specific neural explanation. Your visual cortex normally operates with a background rhythm of electrical activity called alpha oscillations. These oscillations act like a gate, controlling how excitable your visual neurons are at any given moment. Psilocybin strongly suppresses these alpha rhythms in the regions at the back of your brain that process vision.
With that gate removed, spontaneous neural firing in the visual cortex overwhelms the signals coming from your actual eyes. Your brain essentially starts generating its own visual input. Computational models suggest that this increased excitability destabilizes the visual cortex’s normal patterns, producing the geometric shapes, color intensifications, and light patterns people commonly report. Psilocybin also disrupts a specific brain signal involved in recognizing coherent objects in your visual field. When this signal weakens, your brain struggles to construct stable images from what you’re seeing and starts filling in the gaps with its own content, leading to distortions of faces, surfaces, and textures.
Your Brain’s Networks Start Talking Differently
Beyond vision, psilocybin reshapes how entire brain networks communicate. Normally, your brain is organized into distinct networks that handle different jobs: one for attention, one for motor control, one for processing the outside world. These networks maintain clear boundaries, staying relatively segregated from each other. Psilocybin dissolves those boundaries.
Brain imaging research published in Nature found that psilocybin caused more than three times the disruption to functional connectivity compared to a stimulant control drug. The changes were driven by widespread desynchronization: neurons across the brain that normally fire in coordinated rhythms began firing more independently. This reduced the correlations within networks and broke down the anti-correlations between networks, effectively blurring the lines between brain systems that usually operate separately. The result is a brain state with higher entropy, meaning more randomness, unpredictability, and disorderliness in neural firing. This is thought to explain why a trip can feel like your thoughts are less constrained and more free-flowing, with unusual connections between ideas, memories, and sensory experiences.
Why Trips Change Your Sense of Self
One of the most striking effects of psilocybin is ego dissolution, the feeling that the boundary between “you” and the rest of the world is melting away. This maps onto changes in a specific brain system called the default mode network (DMN), a set of interconnected regions most active when you’re daydreaming, reflecting on yourself, or thinking about your past and future. The DMN is closely tied to your sense of being a continuous, separate self.
Psilocybin acutely decreases connectivity and blood flow within the DMN, making this self-referencing network less organized. Researchers have described this as producing “a mind that is less constrained, more flexible, and less self-referential.” Perhaps more striking, psilocybin causes a persistent decrease in connectivity between the hippocampus (involved in memory and spatial awareness) and the default mode network that lasts for weeks after a single dose. This lasting change may help explain why many people describe a shift in perspective that outlasts the trip itself, and why researchers are investigating psilocybin for depression and other conditions where rigid, self-focused thought patterns are a core feature.
What Happens in the Body During a Trip
The effects aren’t limited to perception and thought. Psilocybin raises heart rate and blood pressure, peaking around the two-hour mark alongside the subjective effects. In clinical studies, heart rate rose from a resting baseline of about 68-70 beats per minute to peaks of 82-87 beats per minute. Systolic blood pressure (the top number) climbed from around 125 mmHg at baseline to mean peaks of 139-153 mmHg. These are moderate increases, roughly what you’d see during a brisk walk or a stressful conversation. They return to normal as the drug wears off.
Psilocybin also increases glutamate signaling and glucose metabolism throughout the brain during the roughly six-hour experience. Your brain is burning more energy than usual even as its organized patterns of activity fall apart. This paradox, more metabolic activity paired with less structured communication, is one of the defining features of the psychedelic brain state.
Why the Same Dose Hits People Differently
Two people can eat the same mushroom and have wildly different experiences. Part of this is pharmacological: psilocybin content varies between species and even between individual mushrooms of the same species, ranging from 0.5% to 2% per gram of dried material. A typical dried Psilocybe cubensis mushroom contains roughly 1% psilocybin by weight, making 2.5 grams a standard dose and 3.5 grams a high dose.
But the bigger variable is psychological. Researchers use the terms “set” and “setting” to describe two factors that powerfully shape the experience. Set refers to your mindset going in: your expectations, emotional state, openness to the experience, and whether you feel prepared. Setting refers to your physical and social environment. Clinical trials carefully control both, using calm, dimly lit rooms with curated music and trained guides present. These precautions exist because anxiety during a trip often stems from fighting the experience or being in an unpredictable environment. Having a specific intention, feeling ready, and being in a calm space with people you trust all tilt the odds toward a positive experience. Being resistant, unprepared, or in a chaotic environment does the opposite.
Lasting Changes in the Brain
A single dose of psilocybin doesn’t just temporarily scramble brain activity. It triggers structural changes. Animal studies show that psilocybin induces the growth of new synaptic connections in the cortex and hippocampus, a process called neuroplasticity. In pigs, a single dose increased synaptic density while simultaneously decreasing the density of the very serotonin receptors psilocybin targets, as if the brain is remodeling itself in response to the experience.
This combination of new synaptic connections and persistent shifts in network connectivity is driving significant clinical interest. The FDA has granted psilocybin breakthrough therapy status for its potential in treating depression, and multiple phase 3 clinical trials are currently underway for both treatment-resistant depression and major depressive disorder. No psychedelic is currently FDA-approved, but psilocybin could potentially gain approval within the next couple of years. The therapeutic theory is straightforward: by temporarily disrupting rigid patterns of brain activity and then promoting new neural connections, psilocybin may help people break free from the stuck thought patterns that characterize depression and related conditions.